InvestorsHub Logo
icon url

dmcghee86

11/18/19 11:42 AM

#24909 RE: ramalio #24908

I have positions in both so I see his posts. I was just trying to figure what his motivations are. Sometime the post (although usually negative) have some logical merit to his point of view. Today seems a bit different... oh well.. doesnt matter to me either way just curious
icon url

Laster

11/18/19 12:39 PM

#24913 RE: ramalio #24908

OT. Speaking of which.
Karuna Therapeutics, Inc. (NASDAQ: KRTX) shares surged 233.7% to $58.99 after the company announced its phase 2 trial of KarXT in patients with schizophrenia met its primary endpoint.

David.